Vancomycin and Premature delivery - a phase IV clinical study of FDA data

Summary:

Premature delivery is reported as a side effect among people who take Vancomycin (vancomycin), especially for people who are 30-39 old, have been taking the drug for 1 - 6 months also take Heparin, and have Maternal therapy to enhance foetal lung maturity.

The phase IV clinical study analyzes which people have Premature delivery when taking Vancomycin. It is created by eHealthMe based on reports of 17,160 people who have side effects when taking Vancomycin from the FDA, and is updated regularly.

What is Vancomycin?

Vancomycin has active ingredients of vancomycin. eHealthMe is studying from 17,165 Vancomycin users. Check the latest studies of Vancomycin.

What is Premature delivery?

Premature delivery is found to be associated with 559 drugs and 731 conditions by eHealthMe. Check the latest studies of Premature delivery.

On Jul, 05, 2026

17,160 people reported to have side effects when taking Vancomycin.
Among them, 39 people (0.23%) have Premature delivery.

Could Vancomycin cause Premature delivery?

Among these 39 people:

How long have people been on Vancomycin when they have Premature delivery? *

What is the age of people who have Premature delivery when taking Vancomycin? *

What are other drugs people take besides Vancomycin? *

What are other side effects people have besides Premature delivery? *

Maternal Exposure During Pregnancy (use of substance during pregnancy): 23 people, 58.97%
Stillbirth (a birth of dead foetus): 2 people, 5.13%
Premature Rupture Of Membranes: 2 people, 5.13%
Drug Ineffective: 2 people, 5.13%
Urticaria (rash of round, red welts on the skin that itch intensely): 1 person, 2.56%
Subclavian Vein Thrombosis (abnormal condition in which a clot develops within the subclavian or axillary vein): 1 person, 2.56%
Staphylococcal Infection (an infection with staphylococcus bacteria): 1 person, 2.56%
Normal Newborn: 1 person, 2.56%
Maternal Exposure Before Pregnancy (use of substance before pregnancy): 1 person, 2.56%
Jugular Vein Thrombosis (clot in jugular vein): 1 person, 2.56%

What are the existing conditions these people have? *

Maternal Therapy To Enhance Foetal Lung Maturity: 8 people, 20.51%
Staphylococcal Infection (an infection with staphylococcus bacteria): 6 people, 15.38%
Tocolysis (inhibition of uterine contractions): 5 people, 12.82%
Beta Haemolytic Streptococcal Infection (infection with streptococcus pyogenes, a beta-haemolytic bacterium cause mild to moderately severe respiratory tract, skin, and soft tissue): 3 people, 7.69%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 3 people, 7.69%
Sedation: 3 people, 7.69%
Klebsiella Infection: 2 people, 5.13%
Pulmonary Embolism (blockage of the main artery of the lung): 2 people, 5.13%
Embolism (obstruction of an artery, typically by a clot of blood or an air bubble): 2 people, 5.13%
Escherichia Infection (bacterial infection by escherichia coli): 2 people, 5.13%

* Approximation only. Some reports may have incomplete information.

Do you take Vancomycin and have Premature delivery?

- Check whether Premature delivery is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Vancomycin:

Vancomycin (17,165 reports)

Browse all side effects of Vancomycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Premature delivery:

Premature delivery (559 drugs)

Browse all the conditions that are associated with Premature delivery:

Premature delivery (731 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on vancomycin (the active ingredients of Vancomycin) and Vancomycin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.